The Study: WHIP COVID-19
The “Will Hydroxychloroquine Impede or Prevent COVID-19,” or WHIP COVID-19, study is a 3,000-subject look at whether hydroxychloroquine prevents front-line workers from contracting the COVID-19 virus. This is a randomized, double-blinded study designed to produce a scientific answer to the question: Does it work? Henry Ford Health System, as one of the region’s major academic medical centers with more than $100 million in annual research funding, is also involved in numerous COVID-19 trials with partners around the world.
Participation in this study is completely voluntary. Forms on this website are filled out to indicate a desire to volunteer. Then, an informed consent process will take place with those who potentially meet parameters of the study. During the consent process, volunteers will have an opportunity to have any questions about participation addressed, prior to enrollment in the study. Those who are accepted into the study will need to present their healthcare or first responder employment badge at their first in-person enrollment meeting with study coordinators.